JAC Advance Access originally published online on September 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Journal of Antimicrobial Chemotherapy (2002) 50, 607-609
© 2002 The British Society for Antimicrobial Chemotherapy
Brain tissue penetration of ciprofloxacin following a single intravenous dose
1 Intensive Care Unit and Trauma Center and 3 Department of Neurosurgery, Nord Hospital, Marseilles School of Medicine, Marseilles; 2 Department of Pharmacokinetics, Timone Hospital, France
Received 18 February 2002; returned 8 May 2002; revised 18 June 2002; accepted 15 July 2002
Ciprofloxacin distribution was assessed in cerebral tissues in 14 patients undergoing craniotomy. The study objective was to determine the brain tissue/serum concentration ratio of ciprofloxacin. Patients received a single intravenous (iv) 200 mg dose of ciprofloxacin. Mean (± S.D.) tissue/serum concentration ratios were (mg/kg): parietal fat during opening 1.40 ± 1.05, during closure 1.34 ± 1.17, in the dura mater 2.26 ± 1.36, in skull bone during opening 0.44 ± 0.29, during closure 0.97 ± 1.57 and in brain tissue 0.88 ± 0.99. Mean (± S.D.) concentrations of ciprofloxacin in brain tissue were 0.87 ± 0.08 mg/kg, suggesting that a dose >200 mg iv ciprofloxacin is required to ensure therapeutic concentrations in brain tissue.
* Correspondence address. Service de Réanimation Polyvalente, Hôpital Nord, 13915 Marseille cedex 20, France. Tel: +33-4-91968650; Fax: +33-4-91962818; E-mail: marc.leone{at}ap-hm.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
M. Brunner, O. Langer, G. Dobrozemsky, U. Muller, M. Zeitlinger, M. Mitterhauser, W. Wadsak, R. Dudczak, K. Kletter, and M. Muller [18F]Ciprofloxacin, a New Positron Emission Tomography Tracer for Noninvasive Assessment of the Tissue Distribution and Pharmacokinetics of Ciprofloxacin in Humans Antimicrob. Agents Chemother., October 1, 2004; 48(10): 3850 - 3857. [Abstract] [Full Text] [PDF] |
||||
